CVS Health Forecast, price target & analysts
CVS Health Target price 2025 - Analyst rating & recommendation
CVS Health Classifications & Recommendation:
CVS Health Price Target
| Target Price | $86.70 |
| Price | $76.04 |
| Potential |
14.02%
register free of charge
|
| Number of Estimates | 28 |
|
28 Analysts have issued a price target CVS Health 2026 .
The average CVS Health target price is $86.70.
This is
14.02%
register free of charge
$108.15
42.23%
register free of charge
$70.70
7.02%
register free of charge
|
|
| A rating was issued by 34 analysts: 27 Analysts recommend CVS Health to buy, 7 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the CVS Health stock has an average upside potential 2026 of
14.02%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 372.81 | 401.94 |
| 4.20% | 7.81% | |
| Net Margin | 1.24% | 2.08% |
| 46.93% | 68.06% |
30 Analysts have issued a sales forecast CVS Health 2025 . The average CVS Health sales estimate is
This results in the following potential growth metrics:
31 CVS Health Analysts have issued a net profit forecast 2025. The average CVS Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 3.66 | 6.59 |
| 43.43% | 80.05% | |
| P/E | 11.62 | |
| EV/Sales | 0.38 |
31 Analysts have issued a CVS Health forecast for earnings per share. The average CVS Health EPS is
This results in the following potential growth metrics and future valuations:
Current CVS Health Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Locked
➜
Locked
|
Locked | Nov 13 2025 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Nov 03 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Oct 24 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Nov 13 2025 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Nov 03 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Oct 24 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
